G
GAXOS.AI INC.
Period
FY 2025
Revenue
$1.93M
Net Income
$-3.90M
Total Assets
$13.42M
Equity
$13.13M
Shares Out
10.22M
Op. Cash Flow
$-3.85M
Business
Gaxos.AI is a technology company developing AI-powered solutions across gaming, health, wellness, entertainment, and productivity sectors. The company operates multiple product lines including Gaxos Labs (generative AI services for game developers), UnGPT.ai (AI text enhancement), Art-Gen.AI (image and video creation), Bible Pray AI (spiritual wellness), Gaxos Health (personalized health optimization via biometric data), RNK Health (a majority-owned subsidiary providing supplements and medications), and Gaxos Gaming (five proprietary games with AI and NFT features). Products are distributed through web and mobile platforms.
Summary from 10-K filed 2026-03-17
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| REVENUES | 2 | 4,027 | 256 | — | |
| Research and development | 993,671 | 996,487 | 915,818 | 824,523 | |
| Selling, general and administrative | 6 | 3 | 3 | 599,573 | |
| Total Operating Expenses | 7 | 4 | 4 | 1 | |
| LOSS FROM OPERATIONS | −5 | −4 | −4 | −1 | |
| Interest income | 612,285 | 157,557 | — | — | |
| Unrealized gain on short-term investments | 21,945 | — | 95,785 | — | |
| Realized gain on short-term investments | 30,047 | 121,765 | 20,662 | — | |
| Realized loss on exchange of equity securities | −29,998 | — | — | — | |
| Total other income, net | 634,279 | 279,322 | 67,188 | — | |
| NET LOSS | −4 | −3 | −4 | — | |
| Net loss of subsidiary attributable to noncontrolling interest | 381,664 | 6,086 | — | — | |
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS | −4 | −3 | −4 | −1 | |
| Unrealized gain (loss) on short-term debt investments | 15,283 | −84,092 | — | — | |
| Comprehensive loss | −4 | −4 | −4 | −1 | |
| Basic (in Dollars per share) | −0.55 | −1.92 | −3.9 | −1.64 | |
| Diluted (in Dollars per share) | −0.55 | −1.92 | −3.9 | −1.64 | |
| Basic (in Shares) | 7 | 2 | 987,938 | 868,154 | |
| Diluted (in Shares) | 7 | 2 | 987,938 | 868,154 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2024 2024-05-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|---|
| Cash | 840,799 | 14 | — | 1 | — | |
| Short-term investments, at fair value | 11 | 2 | — | 3 | — | |
| Investment in equity securities, at fair value | 180,000 | 199,998 | 666,660 | — | — | |
| Accounts receivable | 76,247 | — | — | 8 | — | |
| Prepaid expenses and other current assets | 157,586 | 63,609 | — | 25,132 | 400 | |
| Total Current Assets | 13 | 17 | — | 4 | 882,780 | |
| Property and equipment, net | 103,393 | 70,374 | — | 52,606 | — | |
| Intangible assets, net | 718,333 | 125,000 | — | — | 58,647 | |
| Digital currencies | — | 37 | — | 801 | — | |
| Total Long-Term Assets | 821,726 | 195,411 | — | 53,407 | 58,647 | |
| TOTAL ASSETS | 13 | 17 | — | 4 | 941,427 | |
| Accounts payable | 270,105 | 338,791 | — | 215,882 | 245,011 | |
| Accrued expenses | 280,430 | 61,590 | — | 54,154 | 10,683 | |
| Deferred revenue | 130,054 | 1,126 | — | — | — | |
| Total Current Liabilities | 680,589 | 401,507 | — | 270,036 | 255,694 | |
| Total Liabilities | 680,589 | 401,507 | — | 270,036 | 255,694 | |
| Commitments and Contingencies (See Note 8) | — | — | — | — | — | |
| Preferred stock; par value $0.0001; 5,000,000 shares authorized; No shares issued and outstanding on December 31, 2025 and 2024 | — | — | — | — | — | |
| Common stock; par value $0.0001: 50,000,000 shares authorized; 7,123,453 and 6,923,453 shares issued and outstanding on December 31, 2025 and 2024, respectively | 712 | 692 | — | 99 | 87 | |
| Additional paid-in capital | 26 | 25 | — | 9 | 2 | |
| Accumulated other comprehensive income | 26,976 | 11,693 | — | 95,785 | — | |
| Accumulated deficit | −13 | −9 | — | −5 | −1 | |
| Total Gaxos.AI Stockholders Equity | 13 | 17 | — | 3 | 685,733 | |
| Noncontrolling interest | −387,750 | −6,086 | — | — | — | |
| Total Stockholders Equity | 13 | 17 | — | 3 | 685,733 | |
| Total Liabilities and Stockholders Equity | 13 | 17 | — | 4 | 941,427 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Amortization expense | 204,698 | 52,442 | 10,649 | 4,189 | |
| Stock-based compensation | 136,891 | 119,443 | 936,354 | — | |
| Realized loss on exchange of equity securities | 29,998 | — | — | — | |
| Non-cash transaction fees | — | 764 | — | — | |
| Accounts receivable | −76,247 | 8 | −8 | — | |
| Prepaid expenses and other current assets | −93,940 | −38,477 | −24,732 | −400 | |
| Accounts payable | −68,686 | 122,909 | −29,930 | 148,761 | |
| Accrued expenses | 218,840 | 7,436 | 43,471 | 8,197 | |
| Deferred revenue | 128,928 | 1,126 | — | — | |
| NET CASH USED IN OPERATING ACTIVITIES | −4 | −3 | −3 | −1 | |
| Purchase of short-term investments | −16 | −4 | −3 | — | |
| Purchase of equity securities | — | −199,998 | — | — | |
| Proceeds from sale of short-term investments | 7 | 4 | 1 | — | |
| Increase in note receivable | −10,000 | — | — | — | |
| Increase in capitalized internal-use software development costs | −83,050 | −45,210 | −56,971 | — | |
| Purchase of intangible asset | −500,000 | −150,000 | — | −62,836 | |
| NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES | −10 | 67,735 | −3 | −62,836 | |
| Proceeds from the sale of common stock units | — | 8 | 6 | — | |
| Proceeds from exercise of pre-funded warrants | — | 521 | — | — | |
| Proceeds from sale of pre-funded warrants | — | 3 | — | — | |
| Proceeds from exercise of warrants | — | 3 | — | — | |
| Proceeds from induced exercise of warrants | — | 3 | — | — | |
| Purchase and cancellation of treasury shares | — | −19,602 | −99,736 | — | |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | — | 17 | 6 | −75,099 | |
| NET (DECREASE) INCREASE IN CASH | −14 | 13 | 344,929 | −1 | |
| Interest | — | — | — | — | |
| Income taxes | — | — | — | — | |
| Unrealized gain (loss) on short-term investments | 63,761 | −84,092 | — | — | |
| Common stock issued for intangible asset | 248,000 | — | — | — | |
| Exchange of note receivable into investment in equity securities | 10,000 | — | — | — | |
| Reclassification of digital currencies to prepaid expenses and other current assets | 37 | — | — | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Frequently asked questions
What is GAXOS.AI INC.'s CIK number?
GAXOS.AI INC.'s SEC CIK number is 0001895618 (1895618). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find GAXOS.AI INC.'s SEC filings?
All of GAXOS.AI INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.